Anticancer agent with activity against breast cancer cells (IC50s: 6 μM in MCF-7, 10 μM in MDA-MB-231, and 6.4 μM in 4T1 cells); induces cell cycle arrest and mitochondrial-mediated apoptosis in cancer cells; inhibits Akt phosphorylation in human breast and prostate cancers.